IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

TANDA, MARIA LAURA PIERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.616
EU - Europa 5.643
AS - Asia 1.370
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
AF - Africa 4
Totale 16.692
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.588
IT - Italia 2.935
UA - Ucraina 865
SE - Svezia 596
TR - Turchia 409
DE - Germania 342
VN - Vietnam 336
IE - Irlanda 327
CN - Cina 319
FI - Finlandia 214
SG - Singapore 183
GB - Regno Unito 156
FR - Francia 45
JP - Giappone 42
CZ - Repubblica Ceca 36
IN - India 28
RU - Federazione Russa 26
CA - Canada 23
BE - Belgio 18
CH - Svizzera 15
BR - Brasile 14
EU - Europa 14
CL - Cile 13
HK - Hong Kong 13
ES - Italia 12
NL - Olanda 10
AT - Austria 9
BD - Bangladesh 8
AU - Australia 7
NZ - Nuova Zelanda 7
RO - Romania 7
MX - Messico 5
MY - Malesia 5
BY - Bielorussia 4
HR - Croazia 3
IL - Israele 3
KR - Corea 3
MD - Moldavia 3
PH - Filippine 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
EE - Estonia 2
EG - Egitto 2
ID - Indonesia 2
IR - Iran 2
JO - Giordania 2
MK - Macedonia 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 16.692
Salva come PNG Salva come JPEG
Città #
Milan 2.074
Fairfield 1.424
Woodbridge 841
Ashburn 810
Chandler 748
Jacksonville 690
Houston 662
Seattle 564
Wilmington 530
Cambridge 459
Dearborn 369
Ann Arbor 354
Nyköping 328
Dublin 311
Princeton 307
Boardman 218
Izmir 217
Singapore 180
Dong Ket 166
Rome 164
San Diego 103
Como 97
San Mateo 79
New York 74
Ogden 62
Washington 55
Chicago 53
Redmond 53
Beijing 44
Hefei 39
Tokyo 38
Los Angeles 37
Brno 35
Helsinki 35
London 34
Kunming 32
Santa Clara 28
Dallas 27
Düsseldorf 25
Munich 21
Norwalk 21
Brussels 18
Frankfurt am Main 18
Nanjing 18
Varese 18
Berlin 16
Guangzhou 16
Jinan 16
Toronto 13
Nanchang 11
Piacenza 11
Verona 11
Kilburn 9
Phoenix 9
São Paulo 9
Tappahannock 9
Vienna 9
Pune 8
San Francisco 8
Shanghai 8
Gallarate 7
Napoli 7
Shenyang 7
Hong Kong 6
Leinì 6
Paris 6
Redwood City 6
Zhengzhou 6
Budrio 5
Changsha 5
Chengdu 5
Chiswick 5
Falls Church 5
Kuala Lumpur 5
Lappeenranta 5
Mountain View 5
New Bedfont 5
Pavia 5
Prescot 5
Wuhan 5
Bangalore 4
Fuzhou 4
Minsk 4
Ningbo 4
Taiyuan 4
Thamesmead 4
Amsterdam 3
Athis-mons 3
Auckland 3
Carimate 3
Cassano Magnago 3
Chisinau 3
Cormano 3
Edinburgh 3
Fayetteville 3
Hanoi 3
Hebei 3
Kocaeli 3
Livorno Ferraris 3
Madrid 3
Totale 12.820
Salva come PNG Salva come JPEG
Nome #
Simultaneous medullary and papillary thyroid cancer: two case reports. 198
The phenotype of newly diagnosed Graves’ disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study 185
Pituitary apoplexy during pregnancy: A rare, but dangerous headache 184
Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study 181
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid? 180
Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? 180
Antithyroid drug treatment for Graves’ disease: baseline predictive models of relapse after treatment for a patient-tailored management 180
Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study 177
Masked hypertension in newly diagnosed hypothyroidism: a pilot study 175
Disease heterogeneity in IgG4-related hypophysitis: report of two histopathologically proven cases and review of the literature 171
Time interval in diagnosis and treatment of papillary thyroid cancer: a descriptive, retrospective study 170
Continuous monitoring of the recurrent laryngeal nerve in thyroid surgery: a critical appraisal 167
Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs 167
Physical performance in newly diagnosed hypothyroidism: a pilot study 164
Skeletal health in patients with differentiated thyroid carcinoma 164
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity 163
Oral steroid prophylaxis for Graves' orbitopathy after radioactive iodine treatment for Graves' disease is not only effective, but also safe 160
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review 159
Breast cancer and thyroid diseases: analysis of 867 consecutive cases 158
Can combination of glucocorticoids with other immunosoppressive drugs reduce the cumulative dose of glucocorticoids for moderate-to-severe and active Graves' orbitopathy? 158
Minimally invasive follicular thyroid cancer (MIFTC) - A consensus report of the European Society of Endocrine Surgeons (ESES) 154
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 154
Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study 152
Can a patient-tailored treatment approach for Graves' disease reduce mortality? 151
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. 148
Plasma total and acylated ghrelin concentrations in patients with clinical and subclinical thyroid dysfunction 148
Pituitary in black—hypopituitarism secondary to hemosiderosis 147
The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study 146
Shortening Hospital Stay for Thyroid Surgery. 146
Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association 142
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 142
Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal 141
Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature 140
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy 139
Medullary thyroid carcinoma: surgical treatment advances 139
Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study 136
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography 135
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:studies in vivo by color flow Doppler sonography 135
Treating Graves' orbitopathy: where are we? 133
Multidisciplinary Management of Intrathoracic Goiter: A Case Report 133
Thyroid hormone treatment for differentiated thyroid carcinoma: What drug, how long, what dose? 133
Orbital radiotherapy for Graves' ophthalmopathy 132
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy 132
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center 132
Iopanoic acid rapidly controls Type I amiodarone-induced thyrotoxicosis prior to thyroidectomy 130
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study 130
Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations 129
Relationship between management of hyperthyroidism and course of the ophthalmopathy 128
Cigarette smoking and the thyroid 128
Radioiodine and thyroid-associated ophthalmopathy 128
Medullary thyroid carcinoma: surgical treatment advances 127
Orbital radiotherapy for Graves' ophthalmopathy 126
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 126
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? 124
Efficacy and safety of orbital radiotherapy for Graves' orbitopathy 124
Iodine supplementation in women of reproductive age: a survey of clinical practice among Italian gynecologists and midwives 124
Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives. 123
Orbital radiotherapy for Graves' ophthalmopathy 122
Novel approaches to the management of Graves' ophthalmopathy 122
Recent developments in the follow-up, prevention and management of complications in thyroid surgery 122
An update on medical management of Graves' ophthalmopathy 121
Relation between Graves' orbitopathy and radioiodine therapy for hyperthyroidism: facts and unsolved questions 120
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep trying 120
La prevenzione dell'oftalmopatia basedowiana 119
Management of thyroid eye disease 118
An update on the pharmacological management of hyperthyroidism due to Graves' disease 118
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy 118
Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implications 117
Novel immunomodulating agents for Graves orbitopathy 117
Currently available somatostatin analogs are not good for Graves' orbitopathy 116
Thyroid autoimmunity and environment 116
Orbital decompression in Graves' ophthalmopathy by medial and lateral wall removal 115
Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter. 113
Thyroid cancer with tracheal invasion: A pathological estimation 112
The iodine nutritional status in the Italian population: data from the Italian National Observatory for Monitoring Iodine Prophylaxis (OSNAMI) (period 2015–2019) 112
Graves' ophthalmopathy 110
Prevalence and natural history of Graves' orbitopathy in the XXI century 109
Novel treatment modalities for Graves' orbitopathy 108
Amiodarone and the thyroid 108
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European Endocrinologists 104
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement. 102
Severità del Morbo di Basedow di prima diagnosi: ruolo dei linfociti Treg e dei micronutrienti. Dati preliminari di uno studio osservazionale pilota 102
Influence of new technologies on thyroid surgery: state of art 102
Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study 100
Smoking and the Thyroid 98
Amiodarone-unduced thyrotoxicosis. A review 97
Simultaneous Occurrence of Multicentric Medullary and Papillary Thyroid Cancer: A Case Report 96
Gastric Xanthomatous Hyperplastic Polyps – Just an Incidental Endoscopic Finding? 95
La prevenzione della oftalmopatia basedowiana 94
When primary hyperparathyroidism comes as good news 94
Oxidative stress and Graves' ophtalmopathy: in vitro studies and therapeutic implications 92
Ectopic submandibular thyroid tissue with a coexisting normally located multinodular goitre: case report and review of the literature. 91
Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis as compared to subacute thyroiditis 90
Terapia e follow-up dell'ipertiroidismo 89
Analisi dei costi 89
Amyloid goiter 89
Intravenous (IV) and oral (OR) glucocorticoid therapy in patients with severe Graves’ ophthalmopathy (GO): results of a randomized, single-blind, prospective study 88
Image-guided thyroid nodule ablation: technical notes and critical appraisal 87
Graves’ Ophthalmopathy and 131-I therapy 85
Thyroid Hormone Receptors 85
Totale 13.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.574
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.273 0 0 0 0 281 432 485 379 253 208 43 192
2020/20212.746 42 210 120 232 107 319 262 297 369 171 245 372
2021/20221.866 177 170 90 78 113 145 120 90 248 297 131 207
2022/20232.246 274 140 174 235 159 496 16 270 276 85 53 68
2023/20243.652 537 541 550 661 656 347 23 47 108 51 17 114
2024/2025738 22 36 475 134 71 0 0 0 0 0 0 0
Totale 16.973